Letter to the Editor concerning “Serological and clinical evaluation of the Yugoslavian RM 65 sheep pox strain vaccine use in cattle against lumpy skin disease” by Abutarbush and Tuppurainen (Transbound Emerg Dis; 2018: https://doi.org/10.1111/tbed.12923)

2019 ◽  
Vol 66 (2) ◽  
pp. 1090-1091
Author(s):  
Panagiotis D. Katsoulos ◽  
Serafeim C. Chaintoutis ◽  
Eirini I. Agianniotaki ◽  
Chrysostomos I. Dovas ◽  
Constantinos Boscos
Keyword(s):  
Clinical Evaluation ◽  
Skin Disease ◽  
Lumpy Skin Disease ◽  
Letter To The Editor ◽  
Strain Vaccine

scholarly journals Lumpy skin disease in southern Africa : a review of the disease and aspects of control

2001 ◽  
Vol 72 (2) ◽  
Author(s):  
P. Hunter ◽  
D. Wallace
Keyword(s):  
South Africa ◽  
Southern Africa ◽  
Skin Disease ◽  
Control Measures ◽  
Lumpy Skin Disease ◽  
Strain Vaccine ◽  
Successful Control

This article reviews some of the important aspects of lumpy skin disease (LSD) that may impact on its successful control. A resurgence of the disease in the last decade has highlighted some constraints of the Neethling strain vaccine, but there is no evidence of vaccine breakdowns owing to the presence of heterologous field strains. More research is needed on epidemiology and transmission of LSD in South Africa to formulate control measures.

scholarly journals Comparative Evaluation of Lumpy Skin Disease Virus-Based Live Attenuated Vaccines

Vaccines ◽  
2021 ◽  
Vol 9 (5) ◽  
pp. 473
Author(s):  
Andy Haegeman ◽  
Ilse De Leeuw ◽  
Laurent Mostin ◽  
Willem Van Campe ◽  
Laetitia Aerts ◽  
...  
Keyword(s):  
Disease Virus ◽  
Skin Disease ◽  
Vaccination Campaign ◽  
Ease Of Use ◽  
Vaccine Failure ◽  
Lumpy Skin Disease ◽  
Lumpy Skin Disease Virus ◽  
The Balkans ◽  
The Past ◽  
Preventative Strategy

Vaccines form the cornerstone of any control, eradication and preventative strategy and this is no different for lumpy skin disease. However, the usefulness of a vaccine is determined by a multiplicity of factors which include stability, efficiency, safety and ease of use, to name a few. Although the vaccination campaign in the Balkans against lumpy skin disease virus (LSDV) was successful and has been implemented with success in the past in other countries, data of vaccine failure have also been reported. It was therefore the purpose of this study to compare five homologous live attenuated LSDV vaccines (LSDV LAV) in a standardized setting. All five LSDV LAVs studied were able to protect against a challenge with virulent LSDV. Aside from small differences in serological responses, important differences were seen in side effects such as a local reaction and a Neethling response upon vaccination between the analyzed vaccines. These observations can have important implications in the applicability in the field for some of these LSDV LAVs.

scholarly journals Development of a Safe and Highly Efficient Inactivated Vaccine Candidate against Lumpy Skin Disease Virus

Vaccines ◽  
2020 ◽  
Vol 9 (1) ◽  
pp. 4
Author(s):  
Janika Wolff ◽  
Tom Moritz ◽  
Kore Schlottau ◽  
Donata Hoffmann ◽  
Martin Beer ◽  
...  
Keyword(s):  
Skin Disease ◽  
Animal Health ◽  
Vaccine Virus ◽  
Lumpy Skin Disease ◽  
Virus Shedding ◽  
Clinical Protection ◽  
Inactivated Vaccines ◽  
Disease Free ◽  
World Organisation ◽  
Free Status

Capripox virus (CaPV)-induced diseases (lumpy skin disease, sheeppox, goatpox) are described as the most serious pox diseases of livestock animals, and therefore are listed as notifiable diseases under guidelines of the World Organisation for Animal Health (OIE). Until now, only live-attenuated vaccines are commercially available for the control of CaPV. Due to numerous potential problems after vaccination (e.g., loss of the disease-free status of the respective country, the possibility of vaccine virus shedding and transmission as well as the risk of recombination with field strains during natural outbreaks), the use of these vaccines must be considered carefully and is not recommended in CaPV-free countries. Therefore, innocuous and efficacious inactivated vaccines against CaPV would provide a great tool for control of these diseases. Unfortunately, most inactivated Capripox vaccines were reported as insufficient and protection seemed to be only short-lived. Nevertheless, a few studies dealing with inactivated vaccines against CaPV are published, giving evidence for good clinical protection against CaPV-infections. In our studies, a low molecular weight copolymer-adjuvanted vaccine formulation was able to induce sterile immunity in the respective animals after severe challenge infection. Our findings strongly support the possibility of useful inactivated vaccines against CaPV-infections, and indicate a marked impact of the chosen adjuvant for the level of protection.

Seroprevalence and risk factors for lumpy skin disease in cattle in Northern Egypt

2021 ◽  
Vol 53 (3) ◽  
Author(s):  
Abdelfattah Selim ◽  
Eman Manaa ◽  
Hanem Khater
Keyword(s):  
Risk Factors ◽  
Skin Disease ◽  
Lumpy Skin Disease ◽  
Northern Egypt

Development of an inactivated combined vaccine for protection of cattle against Lumpy skin disease and Bluetongue viruses

2021 ◽  
pp. 109046
Author(s):  
Youness Es-sadeqy ◽  
Zahra Bamouh ◽  
Abderrahim Ennahli ◽  
Najete Safini ◽  
Soufiane El Mejdoub ◽  
...  
Keyword(s):  
Skin Disease ◽  
Lumpy Skin Disease ◽  
Combined Vaccine
Sign in / Sign up

Export Citation Format

Share Document